Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Nalbuphine: 0.05 mg/kg intravenous at 0, 2, 5, 15, 30 ,minutes
Control Intervention1: Tramadol: 1mg/kg intravenous at 0, 2, 5, 15, 30 ,minutes
Sponsors
dr d y patil vidyapeeth pimpri pune
dr d y patil vidyapeeth pimpri pune
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patient between 18 years to 60 years of either sex 2. American Society of Anaesthesiologists (ASA) grade I &II undergoing elective surgeries under general anaesthesia � Weight of patient within normal range for that age andsex � Patients who are willing for the study and have given written informed consent
Exclusion criteria
Exclusion criteria: 1.Patients with pre-existing cardiovascular diseases (IHD, hypertension, Valvular Heart diseases, deranged renal or liver functions. 2.Patients with physical dependence to opioids. � Pregnant and lactating females. � Patients with diabetes, asthma, epilepsy, bleeding disorder. � Patients on monoamine oxidase, tricyclic antidepressants, selective serotonin reuptake inhibitors, andwarfarin � History of hypersensitivity to study drugs � Patients not willing to participate in the study will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| for analgesiaTimepoint: 0, 2, 5, 15, 30 ,minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| for analgesiATimepoint: for 30 mins to 2 hrs | — |
Countries
India
Contacts
Public ContactDr Chaitanya Gaidhani
dr. d.. y. patil vidyapeeth
Outcome results
None listed